Annovis Bio (ANVS)

• Market cap: $71.6M
• 1 day: -3.91%
• 5 days: -10.3%
• 1 month: -21.97%
• 3 months: 29.81%
• 6 months: -1.1%
• Year to date: -26.03%
• 1 year: -44.79%
• 5 years: -73.66%
• 10 years: -71.85%
• Sector: Healthcare
• Industry: Biotechnology

About: Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

Employees: 6